We Can't Go on Meeting Like This

Click for larger version (14K) We surveyed our readers to find out if they attend scientific meetings and why they do. Of the 282 who responded, 81% travel to one or more scientific meetings every year. An inveterate 13% go to more than three meetings per year. Readers ranked the importance of various reasons for attending conferences on a 1-to-5 scale, with 5 considered very important. Three motivations stand out: Attending formal lectures and sessions (4.4), meeting informally with collea


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

We surveyed our readers to find out if they attend scientific meetings and why they do. Of the 282 who responded, 81% travel to one or more scientific meetings every year. An inveterate 13% go to more than three meetings per year.

Readers ranked the importance of various reasons for attending conferences on a 1-to-5 scale, with 5 considered very important. Three motivations stand out: Attending formal lectures and sessions (4.4), meeting informally with colleagues (4.3), and visiting poster sessions (4.1). Visiting the commercial exhibit (3.0) came next. Sightseeing (2.9), attending social functions (2.9), and seeking employment opportunities (2.4) were the lowest-ranked reasons.

"We who are supported by federal funds should not use scientific conferences as a front for a vacation or a seven-day binge of overindulgence in free beer," says one reader. Why not, says another: "We only have an allowance to go away once during our PhD study, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio